February 23, 2015 20:48
PITTSBURGH & WASHINGTON--(BUSINESS WIRE)--Tobii Dynavox Supports ‘Steve Gleason Act’; Applauds Congressional Effort to Protect Communication for Those With Disabilities, Including ALS, Cerebral Palsy, Spinal Cord Injury
February 23, 2015 20:47
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. today announced the publication of the second clinical validation study of its multi-analyte test for esophageal cancer. The DecisionDx-EC test analyzes the localization of three protein biomarkers within a patient’s tumor to classify ...
February 23, 2015 20:39
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VERTIFLEX®, INC. ANNOUNCES FDA ADVISORY PANEL SUPPORT FOR THE SUPERION® INTERSPINOUS SPACER
February 23, 2015 20:32
NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals today announced that the company has made significant progress with its rare disease pipeline and expects several approvals and product launches beginning in 2016. In preparation for rolling out its new rare disease treatments, Marathon ...
February 23, 2015 20:30
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation Awards GRU Cancer Center Three-Year, $1.74M Grant to Address Lung Cancer Among Neediest Communities in Central Savannah River Area
February 23, 2015 20:24
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX) today confirmed that the U.S. Food and Drug Administration (FDA) has granted seven years of market exclusivity in the U.S. to Ryanodex® (dantrolene sodium) for Injectable Suspension for the...